{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:33:05Z","timestamp":1790501585569,"version":"4.1.0"},"reference-count":32,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/21645515.2021.1932214","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T18:57:40Z","timestamp":1626461860000},"page":"3771-3783","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-8641","authenticated-orcid":false,"given":"Alhassane","family":"Diallo","sequence":"first","affiliation":[{"name":"CIC-EC 1425, Department of Epidemiology, Biostatistics, Clinical Research, AP-HP Hospital Bichat, University of Paris Diderot, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Carlos-Bolumbu","sequence":"additional","affiliation":[{"name":"D\u00e9partement d'Urgence-R\u00e9animation, Centre Hospitalier Sud-Essones CHSE, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"Cervantes-Gonzalez","sequence":"additional","affiliation":[{"name":"CIC-EC 1425, Department of Epidemiology, Biostatistics, Clinical Research, AP-HP Hospital Bichat, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Wozniak","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University Paris Diderot, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou Hassimiou","family":"Diallo","sequence":"additional","affiliation":[{"name":"Centre population et d\u00e9veloppement, Institut de recherche pour le d\u00e9veloppement, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar Djelo","family":"Diallo","sequence":"additional","affiliation":[{"name":"Facult\u00e9 des Sciences et Techniques de la Sant\u00e9, Universit\u00e9 Gamal Abdel Nasser de Conakry, Service de Pneumo-Phtisiologie, CHU Conakry, H\u00f4pital National Ignace Deen de Conakry, Conakry, Guinea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Delamou","sequence":"additional","affiliation":[{"name":"Gamal Abdel Nasser University, Conakry, Guinea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Galtier","sequence":"additional","affiliation":[{"name":"INSERM, CIC 1411, CHU of Montpellier, Saint Eloi Hospital, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.10.013"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32621-6"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30313-4"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910993"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2016.1187566"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1225637"},{"key":"e_1_3_6_9_1","unstructured":"U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute. Common terminology criteria for adverse events (CTCAE) Version 5.0. 2017 Nov 27."},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-21416-0"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00162-06"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.037"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60553-0"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00154-1"},{"key":"e_1_3_6_16_1","article-title":"Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial","volume":"385","author":"Kibuuka H","year":"2015","unstructured":"Kibuuka H, Berkowitz N, Millard M, Enama M, Tindikahwa A, Sekiziyivu A, Costner P, Sitar S, Glover D, Hu Z, et al. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet Lond Engl. 2015;385:1545\u20101554.","journal-title":"Lancet Lond Engl"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502924"},{"key":"e_1_3_6_18_1","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Tapia M","year":"2016","unstructured":"Tapia M, Sow S, Lyke K, Haidara F, Diallo F, Doumbia M, Traore A, Coulibaly F, Kodio M, Onwuchekwa U, et al. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2016;16:31\u201042.","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00486-7"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.4218"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002402"},{"key":"e_1_3_6_22_1","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu F","year":"2017","unstructured":"Zhu F, Wurie A, Hou L, Liang Q, Li Y, Russell J, Wu SP, Li JX, Hu YM, Guo Q, et al. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Lond Engl. 2017;389:621\u2010628.","journal-title":"Lancet Lond Engl"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614067"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170074"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30367-9"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414216"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz071"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz070"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy020"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix189"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz241"},{"key":"e_1_3_6_32_1","article-title":"Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccines: a randomized double-blind, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Clark DK","year":"2020","unstructured":"Clark DK, Xu R, Matassov D, Latham TE, Ota-Setlik A, Gerardi C, Luckay A, Witko SE, Hermida L, Higgins T, et al. Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccines: a randomized double-blind, placebo-controlled, phase 1 clinical trial. Lancet Infect Dis. 2020;20:455\u201066.","journal-title":"Lancet Infect Dis"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241016"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.1.115"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1932214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:04:26Z","timestamp":1709305466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1932214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/21645515.2021.1932214"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1932214","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}